Related Experiment Video

Updated: May 14, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy

Rokhsana Mortuza1, Subrata Chakrabarti

  • 1Departments of Pathology, Western University, London, ON, N6A 5C1, Canada.

Heart Failure Reviews
|February 23, 2013
PubMed

Insights

Diabetic cardiomyopathy, a complication of diabetes, causes heart failure due to hyperglycemia. This review explores signaling pathways involved and potential treatments for diabetic heart disease.

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Background:

  • Chronic diabetic complications impact multiple organ systems, increasing morbidity and mortality.
  • Diabetic cardiomyopathy is a primary cause of heart failure in diabetic patients.
  • Both endothelial cell and cardiomyocyte dysfunction contribute to diabetic cardiomyopathy pathogenesis.

Purpose of the Study:

  • To review key signaling pathway alterations in diabetic cardiomyopathy.
  • To discuss potential therapeutic interventions for diabetic cardiomyopathy.

Main Methods:

  • This is a review article, synthesizing existing research.
  • Literature search focused on signaling changes and therapeutic strategies in diabetic cardiomyopathy.

Main Results:

  • Hyperglycemia is a key driver of diabetic complications, including oxidative stress and cellular signaling abnormalities.
  • Diabetes-mediated biochemical anomalies interact complexly, affecting transcriptional and post-transcriptional machinery.
  • Altered production of vasoactive and cardioactive factors contributes to cardiac dysfunction.

Conclusions:

  • Understanding diabetes-induced signaling changes is crucial for addressing diabetic cardiomyopathy.
  • Targeting these signaling pathways may offer potential therapeutic avenues for diabetic heart disease.

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...